Literature DB >> 8839688

Bioequivalence assessment and the conduct of bioequivalence trials: a European point of view.

A Herchuelz1.   

Abstract

Mesh:

Year:  1996        PMID: 8839688     DOI: 10.1007/BF03190263

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  3 in total

1.  A distribution-free procedure for the statistical analysis of bioequivalence studies.

Authors:  D Hauschke; V W Steinijans; E Diletti
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-02

2.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

Review 3.  Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.

Authors:  A Marzo; L P Balant
Journal:  Arzneimittelforschung       Date:  1995-02
  3 in total
  3 in total

1.  Bioequivalence testing of a new tablet formulation of generic fluoxetine.

Authors:  D Jovanović; V Kilibarda; S Dordević; M Jovanović; J Jovic-Stosić; D Srdić; T Knezević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

2.  Cubic spline functions and polynomials for calculation of absorption rate.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

Review 3.  The use of GA-RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations-based model) method to optimize bioequivalence studies.

Authors:  Ezequiel Omar Nuske; Mikhail Morozov; Héctor Alejandro Serra
Journal:  Pharmacol Res Perspect       Date:  2021-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.